You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Patent: 7,229,620


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,229,620
Title:Method for radiolabeling antibodies with yttrium-90
Abstract: Methods and kits for radiolabeling proteins, peptides and ligands with radiolytic isotopes, particularly yttrium-90, are disclosed, whereby sufficient purity, specific activity and binding affinity are achieved such that the radiolabeled protein may be directly administered to a patient without further column purification. Such kits and methods will be particularly useful in bringing radioimmunotherapy to the hospital and outpatient setting for the treatment of cancer.
Inventor(s): Chinn; Paul (Carlsbad, CA)
Assignee: Biogen Idec Inc. (Cambridge, MA)
Application Number:11/181,811
Patent Claims:see list of patent claims

Details for Patent 7,229,620

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Acrotech Biopharma Llc ZEVALIN ibritumomab tiuxetan Injection 125019 02/19/2002 ⤷  Try a Trial 2019-03-01
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

International Patent Family for US Patent 7,229,620

Country Patent Number Estimated Expiration
South Africa 200106945 ⤷  Try a Trial
Yugoslavia 61701 ⤷  Try a Trial
World Intellectual Property Organization (WIPO) 0052031 ⤷  Try a Trial
United States of America 7618613 ⤷  Try a Trial
United States of America 6994840 ⤷  Try a Trial
United States of America 2007297978 ⤷  Try a Trial
United States of America 2006067884 ⤷  Try a Trial
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.